These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19776336)

  • 1. A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease.
    Varani K; Vincenzi F; Tosi A; Gessi S; Casetta I; Granieri G; Fazio P; Leung E; MacLennan S; Granieri E; Borea PA
    FASEB J; 2010 Feb; 24(2):587-98. PubMed ID: 19776336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A(2A) adenosine receptors and Parkinson's disease severity.
    Casetta I; Vincenzi F; Bencivelli D; Corciulo C; Gentile M; Granieri E; Borea PA; Varani K
    Acta Neurol Scand; 2014 Apr; 129(4):276-81. PubMed ID: 24032478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
    Kreckler LM; Wan TC; Ge ZD; Auchampach JA
    J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.
    Varani K; Caramori G; Vincenzi F; Tosi A; Barczyk A; Contoli M; Casolari P; Triggiani M; Hansel T; Leung E; Maclennan S; Barnes PJ; Chung KF; Adcock I; Papi A; Borea PA
    FASEB J; 2010 Apr; 24(4):1192-204. PubMed ID: 20008542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of free radicals on adenosine A(2A) and dopamine D2 receptors in the striatum of young adult and aged rats.
    Alfaro TM; Vigia E; Oliveira CR; Cunha RA
    Neurochem Int; 2004 Oct; 45(5):733-8. PubMed ID: 15234116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide and TNF-alpha modify adenosine A(2A) receptor expression and function in equine monocytes.
    Sun WC; Berghaus LJ; Moore JN; Hurley DJ; Vandenplas ML; Thompson R; Linden J
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):289-95. PubMed ID: 20056284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
    Trincavelli ML; Marroni M; Tuscano D; Ceruti S; Mazzola A; Mitro N; Abbracchio MP; Martini C
    J Neurochem; 2004 Dec; 91(5):1180-90. PubMed ID: 15569261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia.
    van der Putten C; Zuiderwijk-Sick EA; van Straalen L; de Geus ED; Boven LA; Kondova I; IJzerman AP; Bajramovic JJ
    J Immunol; 2009 Jun; 182(12):7603-12. PubMed ID: 19494284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders.
    Kulisevsky J; Poyurovsky M
    Eur Neurol; 2012; 67(1):4-11. PubMed ID: 22134373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease.
    Kalda A; Yu L; Oztas E; Chen JF
    J Neurol Sci; 2006 Oct; 248(1-2):9-15. PubMed ID: 16806272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
    Morelli M; Di Paolo T; Wardas J; Calon F; Xiao D; Schwarzschild MA
    Prog Neurobiol; 2007 Dec; 83(5):293-309. PubMed ID: 17826884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptors and Parkinson's disease.
    Morelli M; Carta AR; Jenner P
    Handb Exp Pharmacol; 2009; (193):589-615. PubMed ID: 19639294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Pinna A; Pontis S; Borsini F; Morelli M
    Synapse; 2007 Aug; 61(8):606-14. PubMed ID: 17476684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
    Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
    Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
    Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
    Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
    Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
    Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease.
    Fuxe K; Marcellino D; Genedani S; Agnati L
    Mov Disord; 2007 Oct; 22(14):1990-2017. PubMed ID: 17618524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.